On Thursday, March 13 from 4:00-5:00 PM in RHPH 164, Dr. Matthew Kennedy (Scientific Associate Vice President, Drug Discovery Scientist, Merck & Co. Inc) will be presenting “Tackling Alzheimer’s Disease at its Core: Therapeutic Strategies, Challenges, and Prospects” for the Borch Department of Medicinal Chemistry and Molecular Pharmacology. Please see the attached flyer for details!
